Horizon Discovery Introduces Single Cell RNAseq-Linked CRISPR Screening Service
Single cell RNAseq-linked pooled CRISPR screening offers high-quality screening data and biological insight
Company aims to develop the next generation of engineered CHO cell lines to improve production of biotherapeutics
Next-generation gene editing system has applications in development of cell and gene therapies
Agreement will expand open access resource, supporting genetic research globally
Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business
First-to-market cell line-derived reference standard for myeloid blood cancers
Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation